Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Institut Bergonié
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Situs Cancer Research Center
Sarcoma Oncology Research Center, LLC
ImmunityBio, Inc.
ImmunityBio, Inc.
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Brown University
Wake Forest University Health Sciences
University of California, Davis
Boehringer Ingelheim
Sarcoma Oncology Research Center, LLC
University of Southern California
OHSU Knight Cancer Institute
Pfizer
Ohio State University Comprehensive Cancer Center
Translational Research in Oncology
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Aesculap AG
Peking University People's Hospital
Emory University
University of Wisconsin, Madison
Presage Biosciences
University of Texas Southwestern Medical Center
Organon and Co
M.D. Anderson Cancer Center
Agenus Inc.
Deciphera Pharmaceuticals, LLC
Brown University
Australia New Zealand Gynaecological Oncology Group
Brown University
Boston Scientific Corporation
Abramson Cancer Center at Penn Medicine
NKGen Biotech, Inc.
Jonsson Comprehensive Cancer Center
Columbia University
Dana-Farber Cancer Institute
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Peking University People's Hospital
Peking University People's Hospital
National Institutes of Health Clinical Center (CC)
Oregon Health and Science University
GlaxoSmithKline
Fred Hutchinson Cancer Center
Washington University School of Medicine